Progress and prospects: gene therapy for genetic diseases with helper-dependent adenoviral vectors.
about
Epithelial cell coculture models for studying infectious diseases: benefits and limitationsThe role of chromatin in adenoviral vector functionBarriers to inhaled gene therapy of obstructive lung diseases: A reviewEnhanced anti-tumor effects of combined MDR1 RNA interference and human sodium/iodide symporter (NIS) radioiodine gene therapy using an adenoviral system in a colon cancer model.Delivery of an EBV episome by a self-circularizing helper-dependent adenovirus: long-term transgene expression in immunocompetent mice.Species differences in the pharmacology and toxicology of PEGylated helper-dependent adenovirusFerret and pig models of cystic fibrosis: prospects and promise for gene therapy.Cystic Fibrosis Gene Therapy in the UK and Elsewhere.An Engineered Endomorphin-2 Gene for Morphine Withdrawal SyndromeGene Therapy Targeting LDL Cholesterol but not HDL Cholesterol Induces Regression of Advanced Atherosclerosis in a Mouse Model of Familial HypercholesterolemiaA rapid Q-PCR titration protocol for adenovirus and helper-dependent adenovirus vectors that produces biologically relevant results.Gene therapy for inborn errors of liver metabolism: progress towards clinical applicationsProspects, promise and problems on the road to effective vaccines and related therapies for substance abuseIntegration profile and safety of an adenovirus hybrid-vector utilizing hyperactive sleeping beauty transposase for somatic integration.DRG-targeted helper-dependent adenoviruses mediate selective gene delivery for therapeutic rescue of sensory neuronopathies in mice.Antioxidant enzyme gene transfer for ischemic diseases.Limitations of Adenoviral Vector-Mediated Delivery of Gold Nanoparticles to Tumors for Hyperthermia Induction.Solid lipid nanoparticles for applications in gene therapy: a review of the state of the art.Progress and prospects: Immunobiology of gene therapy for neurodegenerative disease: prospects and risks.Gene therapy for pulmonary hypertension: prospects and challenges.Gene therapy with helper-dependent adenoviral vectors: current advances and future perspectives.Perspectives and challenges of antioxidant therapy for atrial fibrillation.Cystic fibrosis gene therapy: successes, failures and hopes for the future.High-level production of replication-defective human immunodeficiency type 1 virus vector particles using helper-dependent adenovirus vectors.Helper-dependent adenovirus achieve more efficient and persistent liver transgene expression in non-human primates under immunosuppression.Capsid-modified adenoviral vectors for improved muscle-directed gene therapyRescue administration of a helper-dependent adenovirus vector with long-term efficacy in dogs with glycogen storage disease type Ia.Self-inactivating helper virus for the production of high-capacity adenoviral vectors.Readministration of helper-dependent adenoviral vectors to mouse airway mediated via transient immunosuppression.
P2860
Q21296749-444A0B6D-8660-40AD-8ACD-67094D409278Q27004695-79FBF50D-2201-4CEE-A550-123FA55283E5Q29248141-94193EC5-CA02-44D1-A23F-10C22AD35998Q33920953-A479853A-D92E-4AED-BA88-9A660954ADA4Q34586535-D8F71378-E587-4371-B0E3-0FF3923BA2CEQ34975214-F1D7F036-D8E7-47DD-AE6A-2877786E3BFFQ35200182-8CAD6F90-F663-4F37-9550-3120373665E8Q35641704-9FD9531A-7384-4B35-95A2-4CCEA0E51CA6Q35966106-AD8C5152-D9D5-439E-9F82-74AE7558D239Q36344509-20D21173-71D4-494B-98DF-5D56CFDBD682Q36920480-9D7859A3-3557-4EC4-9419-16F61C5406C9Q37015311-143F7749-12FE-4649-8067-018428FDE286Q37082158-91D8BAB8-C674-4DE1-9097-5AD051145F11Q37215836-B0A80CBD-7887-4222-98A5-D55AD0415F82Q37241434-CB2E0C5C-F33D-4D89-AB36-D44A16601839Q37398189-249B5ABF-8A64-4C1A-818A-8C531D6BCA6CQ37438361-AF42C21E-17CA-4B88-A908-8A60BAC8767FQ37657507-EEB8D48A-5508-4E6B-BE06-85BEFE81DF16Q37690581-AFD3E9C1-5B50-4DFB-BE49-C11575C1C657Q37827155-F1CFF767-8CD0-46E3-8B67-7FD09FC41FBDQ37945218-282C86A6-22BE-4882-B47C-0672D2136A7DQ39024113-708D2DE8-CAB7-48C5-9EB4-0ECF36CC0C1BQ39872579-7BE75F94-CD99-402F-BD11-D01DAAB18BE9Q41124092-DF6BB8E1-0C57-4AFA-AFCF-CE645A39A1BCQ41627013-1DD7DCD8-12F8-4482-9D23-62FBDD930340Q42424335-EBF207FB-595C-4BBD-9050-52BF9A6756F8Q44199828-1318EF69-AEE8-4911-A5EB-1C3D26997D98Q45367025-342E6255-44D9-4DBB-A2F6-F435EE955C39Q45863903-DFEEF0A0-D7D7-4DB6-9D6D-6883F22CEF70
P2860
Progress and prospects: gene therapy for genetic diseases with helper-dependent adenoviral vectors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Progress and prospects: gene t ...... -dependent adenoviral vectors.
@en
Progress and prospects: gene t ...... -dependent adenoviral vectors.
@nl
type
label
Progress and prospects: gene t ...... -dependent adenoviral vectors.
@en
Progress and prospects: gene t ...... -dependent adenoviral vectors.
@nl
prefLabel
Progress and prospects: gene t ...... -dependent adenoviral vectors.
@en
Progress and prospects: gene t ...... -dependent adenoviral vectors.
@nl
P2860
P921
P356
P1433
P1476
Progress and prospects: gene t ...... r-dependent adenoviral vectors
@en
P2860
P2888
P304
P356
10.1038/GT.2008.14
P577
2008-02-21T00:00:00Z